LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

Search

Illumina Inc

Fechado

SetorSaúde

94.76 0.77

Visão Geral

Variação de preço das ações

24h

Atual

Mín

92.71

Máximo

95.57

Indicadores-chave

By Trading Economics

Rendimento

-56M

131M

Vendas

-63M

1B

EPS

0.97

Margem de lucro

12.584

Funcionários

8,970

EBITDA

-8M

276M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+11.51% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de ago. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-2B

14B

Abertura anterior

93.99

Fecho anterior

94.76

Sentimento de Notícias

By Acuity

23%

77%

45 / 380 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

Illumina Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

11 de mar. de 2025, 09:18 UTC

Ações em Alta

Stocks to Watch Tuesday: Tesla, Oracle, Delta, Nvidia -- WSJ

10 de mar. de 2025, 21:07 UTC

Principais Notícias

Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban -- WSJ

10 de mar. de 2025, 20:01 UTC

Principais Notícias

Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban -- WSJ

4 de mar. de 2025, 10:56 UTC

Ações em Alta

Stocks to Watch Tuesday: Illumina, Nvidia, Stellantis -- WSJ

Comparação entre Pares

Variação de preço

Illumina Inc Previsão

Preço-alvo

By TipRanks

11.51% parte superior

Previsão para 12 meses

Média 105 USD  11.51%

Máximo 185 USD

Mínimo 70 USD

Com base em 16 analistas de Wall Street que oferecem metas de preço de 12 meses para Illumina Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

16 ratings

7

Comprar

7

Manter

2

Vender

Pontuação Técnica

By Trading Central

77.61 / N/ASuporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

45 / 380 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.